(IOCT) Innovator s Trust - Overview
Etf: FLEX Options, EAFE ETF, Options Contracts
| Risk 5d forecast | |
|---|---|
| Volatility | 8.10% |
| Relative Tail Risk | 2.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.43 |
| Alpha | 11.05 |
| Character TTM | |
|---|---|
| Beta | 0.365 |
| Beta Downside | 0.330 |
| Drawdowns 3y | |
|---|---|
| Max DD | 7.54% |
| CAGR/Max DD | 1.76 |
Description: IOCT Innovator s Trust January 24, 2026
The Innovator International Developed Power Buffer ETF (IOCT) is a non-diversified, “Defined Outcome” ETF that must allocate at least 80 % of its net assets to FLEX Options tied to the iShares MSCI EAFE ETF. FLEX Options are customizable, exchange-traded contracts cleared through the OCC, which guarantees settlement but still carries OCC counter-party risk and typically lower liquidity than standard options.
Key operational metrics (as of the most recent filing) include an expense ratio of roughly 0.79 %, assets under management near $120 million, and a buffer structure that aims to deliver up to a 6 % upside participation while limiting downside losses to about 15 % over the calendar year. The fund’s performance is heavily influenced by the EAFE region’s equity market volatility, the USD/major-currency exchange rate, and global interest-rate trends, all of which affect the pricing and hedge effectiveness of the underlying FLEX Options.
Investors should monitor the fund’s FLEX Options open interest and bid-ask spreads, as illiquidity can widen execution costs, and stay aware of any OCC policy changes that could alter counter-party exposure. For a deeper dive into how IOCT’s buffer strategy behaves across different market regimes, you might find the analytics on ValueRay worth exploring.
What is the price of IOCT shares?
Over the past week, the price has changed by +0.87%, over one month by +2.03%, over three months by +5.72% and over the past year by +19.05%.
Is IOCT a buy, sell or hold?
What are the forecasts/targets for the IOCT price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 40.4 | 12.3% |
IOCT Fundamental Data Overview February 01, 2026
EBIT TTM = 0.0 USD
EBITDA TTM = 0.0 USD
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 190.1m USD (190.1m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
EV/FCF = unknown (FCF TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 190.1m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 190.1m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 21.0% (US default 21%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 21.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 7.26% (E(190.1m)/V(190.1m) * Re(7.26%) + (debt-free company))
Discount Rate = 7.26% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Fair Price DCF = unknown (Cash Flow 0.0)